SLUG/SNAI2 and Tumor Necrosis Factor Generate Breast Cells With CD44+/CD24-Phenotype

被引:146
作者
Bhat-Nakshatri, Poornima [1 ]
Appaiah, Hitesh [1 ]
Ballas, Christopher [2 ]
Pick-Franke, Patricia [4 ]
Goulet, Robert, Jr. [1 ]
Badve, Sunil [3 ]
Srour, Edward F. [2 ]
Nakshatri, Harikrishna [1 ,4 ]
机构
[1] Indiana Univ Sch Med, Dept Surg, Indianapolis, IN 46202 USA
[2] Indiana Univ Sch Med, Dept Med, Indianapolis, IN 46202 USA
[3] Indiana Univ Sch Med, Dept Pathol, Indianapolis, IN 46202 USA
[4] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA
来源
BMC CANCER | 2010年 / 10卷
关键词
CANCER STEM-CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; E-CADHERIN EXPRESSION; TRANSCRIPTION FACTOR SNAIL; REPRESSES E-CADHERIN; BASAL-LIKE PHENOTYPE; ESTROGEN-RECEPTOR; KAPPA-B; PROGENITOR CELLS; SELF-RENEWAL;
D O I
10.1186/1471-2407-10-411
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Breast cancer cells with CD44+/CD24- cell surface marker expression profile are proposed as cancer stem cells (CSCs). Normal breast epithelial cells that are CD44+/CD24- express higher levels of stem/progenitor cell associated genes. We, amongst others, have shown that cancer cells that have undergone epithelial to mesenchymal transition (EMT) display the CD44+/CD24- phenotype. However, whether all genes that induce EMT confer the CD44+/CD24- phenotype is unknown. We hypothesized that only a subset of genes associated with EMT generates CD44+/CD24- cells. Methods: MCF-10A breast epithelial cells, a subpopulation of which spontaneously acquire the CD44+/CD24- phenotype, were used to identify genes that are differentially expressed in CD44+/CD24- and CD44-/CD24+ cells. Ingenuity pathway analysis was performed to identify signaling networks that linked differentially expressed genes. Two EMT-associated genes elevated in CD44+/CD24- cells, SLUG and Gli-2, were overexpressed in the CD44-/CD24+ subpopulation of MCF-10A cells and MCF-7 cells, which are CD44-/CD24+. Flow cytometry and mammosphere assays were used to assess cell surface markers and stem cell-like properties, respectively. Results: Two thousand thirty five genes were differentially expressed (p < 0.001, fold change >= 2) between the CD44+/CD24- and CD44-/CD24+ subpopulations of MCF-10A. Thirty-two EMT-associated genes including SLUG, Gli-2, ZEB-1, and ZEB-2 were expressed at higher levels in CD44+/CD24- cells. These EMT-associated genes participate in signaling networks comprising TGF beta, NF-kappa B, and human chorionic gonadotropin. Treatment with tumor necrosis factor (TNF), which induces NF-kappa B and represses E-cadherin, or overexpression of SLUG in CD44-/CD24+ MCF-10A cells, gave rise to a subpopulation of CD44+/CD24- cells. Overexpression of constitutively active p65 subunit of NF kappa B in MCF-10A resulted in a dramatic shift to the CD44+/CD24+ phenotype. SLUG overexpression in MCF-7 cells generated CD44+/CD24+ cells with enhanced mammosphere forming ability. In contrast, Gli-2 failed to alter CD44 and CD24 expression. Conclusions: EMT-mediated generation of CD44+/CD24- or CD44+/CD24+ cells depends on the genes that induce or are associated with EMT. Our studies reveal a role for TNF in altering the phenotype of breast CSC. Additionally, the CD44+/CD24+ phenotype, in the context of SLUG overexpression, can be associated with breast CSC "stemness" behavior based on mammosphere forming ability.
引用
收藏
页数:16
相关论文
共 69 条
[1]   Prospective identification of tumorigenic breast cancer cells [J].
Al-Hajj, M ;
Wicha, MS ;
Benito-Hernandez, A ;
Morrison, SJ ;
Clarke, MF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (07) :3983-3988
[2]   Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype [J].
Balic, Marija ;
Lin, Henry ;
Young, Lillian ;
Hawes, Debra ;
Giuliano, Armando ;
McNamara, George ;
Datar, Ram H. ;
Cote, Richard J. .
CLINICAL CANCER RESEARCH, 2006, 12 (19) :5615-5621
[3]   The transcription factor Snail is a repressor of E-cadherin gene expression in epithelial tumour cells [J].
Batlle, E ;
Sancho, E ;
Franci, C ;
Domínguez, D ;
Monfar, M ;
Baulida, J ;
de Herreros, AG .
NATURE CELL BIOLOGY, 2000, 2 (02) :84-89
[4]   Will cancer stem cells provide new therapeutic targets? [J].
Behbod, F ;
Rosen, JM .
CARCINOGENESIS, 2005, 26 (04) :703-711
[5]   An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors [J].
Ben-Porath, Ittai ;
Thomson, Matthew W. ;
Carey, Vincent J. ;
Ge, Ruping ;
Bell, George W. ;
Regev, Aviv ;
Weinberg, Robert A. .
NATURE GENETICS, 2008, 40 (05) :499-507
[6]   Mouse cDNA microarray analysis uncovers Slug targets in mouse embryonic fibroblasts [J].
Bermejo-Rodríguez, C ;
Pérez-Caro, M ;
Pérez-Mancera, PA ;
Sánchez-Beato, M ;
Piris, MA ;
Sánchez-García, I .
GENOMICS, 2006, 87 (01) :113-118
[7]   Identification of signal transduction pathways involved in constitutive NF-κB activation in breast cancer cells [J].
Bhat-Nakshatri, P ;
Sweeney, CJ ;
Nakshatri, H .
ONCOGENE, 2002, 21 (13) :2066-2078
[8]   AKT Alters Genome-Wide Estrogen Receptor α Binding and Impacts Estrogen Signaling in Breast Cancer [J].
Bhat-Nakshatri, Poornima ;
Wang, Guohua ;
Appaiah, Hitesh ;
Luktuke, Nikhil ;
Carroll, Jason S. ;
Geistlinger, Tim R. ;
Brown, Myles ;
Badve, Sunil ;
Liu, Yunlong ;
Nakshatri, Harikrishna .
MOLECULAR AND CELLULAR BIOLOGY, 2008, 28 (24) :7487-7503
[9]   Cell type-specific DNA methylation patterns in the human breast [J].
Bloushtain-Qimron, Noga ;
Yao, Jun ;
Snyder, Eric L. ;
Shipitsin, Michail ;
Campbell, Lauren L. ;
Mani, Sendurai A. ;
Hua, Min ;
Chen, Haiyan ;
Ustyansky, Vadim ;
Antosiewicz, Jessica E. ;
Argani, Pedram ;
Halushka, Marc K. ;
Thomson, James A. ;
Pharoah, Paul ;
Porgador, Angel ;
Sukumar, Saraswati ;
Parsons, Ramon ;
Richardson, Andrea L. ;
Stampfer, Martha R. ;
Gelman, Rebecca S. ;
Nikolskaya, Tatiana ;
Nikolsky, Yuri ;
Polyak, Kornelia .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (37) :14076-14081
[10]   Induction and regulation of epithelial-mesenchymal transitions [J].
Boyer, B ;
Vallés, AM ;
Edme, N .
BIOCHEMICAL PHARMACOLOGY, 2000, 60 (08) :1091-1099